SV Health Investors

News, insights, analysis and data

SV Health Investors overview

Stories about SV Health Investors

Picture of the Company

SV Health Investors raises $400m

View the latest capital raises

Picture of the Company

US healthcare funds target changing sector

SV Life Sciences and Linden have closed funds totaling some $900m to target a sector bracing for big regulatory changes.

Picture of the Company

Nelson leaves SV Life Sciences to launch firm

Donald Nelson, former investor relations head of the Boston-based life sciences venture capital firm, has left to form NelCap Advisers, his own placement agency and consulting firm.

SV Health Investors contact information

Offices

marker icon28 State Street, Financial District, Downtown, Suffolk County, Boston, 02109, United States
Showing 1 of 2 SV Health Investors offices

Contacts

NameJob titleLocationEmail
Key Contact
user imageMs. Georgina Ewels
Job titleDirector, Investor Relations, Impact & Fundraising
LocationLondon, United Kingdom
Emaillock image-----
user imageMr. James Costine
Job titleChief Financial Officer (UK) and Partner
LocationLondon, United Kingdom
Emaillock image-----
user imageMr. Brent Faduski
Job titleChief Financial Officer, Chief Compliance Officer and Partner
LocationBoston, United States
Emaillock image------
user imageMr. Paul LaViolette
Job titleManaging Partner, COO & Head, Medical Device Investments
LocationBoston, United States
Emaillock image-----------

SV Health Investors funds managed

Funds in market: 2

FundFund sizeOpen dateStrategy
Fund sizelock image--------
Open dateMar 2025
Strategylock image-----------
Fund sizelock image--------
Open dateNov 2024
Strategylock image-------

Closed funds: 11

FundFund sizeClose dateStrategy
Fund sizelock image-----
Close dateMay 2025
Strategylock image-------
Fund sizelock image---------
Close dateDec 2021
Strategylock image-----
Fund sizelock image----------
Close dateJul 2020
Strategylock image---------

Stories that mention SV Health Investors

A-Z of Healthcare: A-E

In the first part of our A-Z, we examine ancillary healthcare, biotech, covid-19, digitisation and eldercare.

Teijin approves $90m commitment

The Japanese chemicals company has backed a US healthcare fund.

Cinven acquires $1.4bn clinical trials provider

Cinven has acquired clinical trials services provider Bioclinica from US private equity firms Water Street Healthcare Partners and JLL Partners.

Summit hires healthcare execs for US and Europe

The firm has hired managing director Darren Black (pictured) and principal Thomas Tarnowski to focus on healthcare and life sciences investments.

RoundTable raises $800m for healthcare

Healthcare reform in the US will create opportunities over the next five years, according to RoundTable co-chair Lester Knight.

Ross pledges $1bn for healthcare investments

Wilbur Ross is forming a joint venture with the former chairman of CVSCaremark to take advantage of opportunities created by US healthcare reform.